Next Article in Journal
Comparison of PLA-Based Micelles and Microspheres as Carriers of Epothilone B and Rapamycin. The Effect of Delivery System and Polymer Composition on Drug Release and Cytotoxicity against MDA-MB-231 Breast Cancer Cells
Next Article in Special Issue
Immunotherapy for Triple-Negative Breast Cancer
Previous Article in Journal
Microbial Fibrinolytic Enzymes as Anti-Thrombotics: Production, Characterisation and Prodigious Biopharmaceutical Applications
Previous Article in Special Issue
Tuning the Cytotoxicity of Bis-Phosphino-Amines Ruthenium(II) Para-Cymene Complexes for Clinical Development in Breast Cancer
Review

Circulating Tumour Cells (CTCs) in NSCLC: From Prognosis to Therapy Design

1
Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital, 128 08 Prague, Czech Republic
2
BIOCEV, First Faculty of Medicine, Charles University, 252 50 Vestec, Czech Republic
3
Department of Analytical Chemistry, Faculty of Chemical Engineering, University of Chemistry and Technology, 166 28 Prague, Czech Republic
4
1st Department of Surgery-Department of Abdominal, Thoracic Surgery and Traumatology, First Faculty of Medicine, Charles University and General University Hospital, 121 08 Prague, Czech Republic
5
Department of Respiratory Medicine, First Faculty of Medicine, Charles University and Thomayer Hospital, 140 59 Prague, Czech Republic
6
Institute of Molecular Genetics, Czech Academy of Sciences, 142 20 Prague, Czech Republic
*
Author to whom correspondence should be addressed.
Academic Editor: Hassan Bousbaa
Pharmaceutics 2021, 13(11), 1879; https://doi.org/10.3390/pharmaceutics13111879
Received: 27 September 2021 / Revised: 27 October 2021 / Accepted: 30 October 2021 / Published: 5 November 2021
(This article belongs to the Special Issue Novel Anticancer Strategies (Volume II))
Designing optimal (neo)adjuvant therapy is a crucial aspect of the treatment of non-small-cell lung carcinoma (NSCLC). Standard methods of chemotherapy, radiotherapy, and immunotherapy represent effective strategies for treatment. However, in some cases with high metastatic activity and high levels of circulating tumour cells (CTCs), the efficacy of standard treatment methods is insufficient and results in treatment failure and reduced patient survival. CTCs are seen not only as an isolated phenomenon but also a key inherent part of the formation of metastasis and a key factor in cancer death. This review discusses the impact of NSCLC therapy strategies based on a meta-analysis of clinical studies. In addition, possible therapeutic strategies for repression when standard methods fail, such as the administration of low-toxicity natural anticancer agents targeting these phenomena (curcumin and flavonoids), are also discussed. These strategies are presented in the context of key mechanisms of tumour biology with a strong influence on CTC spread and metastasis (mechanisms related to tumour-associated and -infiltrating cells, epithelial–mesenchymal transition, and migration of cancer cells). View Full-Text
Keywords: CTCs; NSCLCs; metastasis suppression; curcumin; flavonoids CTCs; NSCLCs; metastasis suppression; curcumin; flavonoids
Show Figures

Graphical abstract

MDPI and ACS Style

Kejík, Z.; Kaplánek, R.; Dytrych, P.; Masařík, M.; Veselá, K.; Abramenko, N.; Hoskovec, D.; Vašáková, M.; Králová, J.; Martásek, P.; Jakubek, M. Circulating Tumour Cells (CTCs) in NSCLC: From Prognosis to Therapy Design. Pharmaceutics 2021, 13, 1879. https://doi.org/10.3390/pharmaceutics13111879

AMA Style

Kejík Z, Kaplánek R, Dytrych P, Masařík M, Veselá K, Abramenko N, Hoskovec D, Vašáková M, Králová J, Martásek P, Jakubek M. Circulating Tumour Cells (CTCs) in NSCLC: From Prognosis to Therapy Design. Pharmaceutics. 2021; 13(11):1879. https://doi.org/10.3390/pharmaceutics13111879

Chicago/Turabian Style

Kejík, Zdeněk, Robert Kaplánek, Petr Dytrych, Michal Masařík, Kateřina Veselá, Nikita Abramenko, David Hoskovec, Martina Vašáková, Jarmila Králová, Pavel Martásek, and Milan Jakubek. 2021. "Circulating Tumour Cells (CTCs) in NSCLC: From Prognosis to Therapy Design" Pharmaceutics 13, no. 11: 1879. https://doi.org/10.3390/pharmaceutics13111879

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop